Business ❯Pharmaceutical Industry ❯Drug Development
Stock Performance Novo Nordisk GLP-1 Agonists Eli Lilly Obesity Drug Market
The FDA-approved drug for obstructive sleep apnea marks a significant expansion of access to costly weight-loss medications under Medicare Part D plans.
